Planet 13 Holdings (PLNH) Total Current Liabilities (2021 - 2026)
Planet 13 Holdings' (PLNH) quarterly Total Current Liabilities came in at $21.3 million in Q1 2026, down 15.63% year-on-year from $25.3 million in Q1 2025, and down 7.87% on a QoQ basis from $23.1 million in Q4 2025.
Planet 13 Holdings (PLNH) Total Current Liabilities (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has 6 years of Total Current Liabilities data on file, last reported at $21.3 million in Q1 2026.
- On a quarterly basis, Total Current Liabilities fell 15.63% year-over-year to $21.3 million in Q1 2026; TTM through Mar 2026 was $21.3 million, a 15.63% decrease from a year earlier, with the FY2025 full-year figure at $23.1 million, down 8.71% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $21.3 million, down from $23.1 million in the prior quarter.
- Over the last five years, Total Current Liabilities for PLNH reached as high as $42.6 million in Q3 2024 and fell as low as $9.9 million in Q2 2022.
- Historically, Total Current Liabilities has averaged $20.4 million across 5 years, with a median of $16.3 million in 2024.
- Across the five-year window, Total Current Liabilities surged 219.3% in 2024 and sank 37.82% in 2025, its largest moves.
- Year by year, Total Current Liabilities stood at $15.4 million in 2022, then decreased by 0.55% to $15.3 million in 2023, then jumped by 65.78% to $25.3 million in 2024, then decreased by 8.71% to $23.1 million in 2025, then retreated by 7.87% to $21.3 million in 2026.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $21.3 million in Q1 2026, $23.1 million in Q4 2025, and $26.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.56 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.53 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 18.06 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 599.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 6.81 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 831.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.66 Bn |
| 10 | Planet 13 Holdings | 39.35 Mn | 23.09 Mn | 9.41 Mn | 21.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.32 Mn |
| Dec 31, 2025 | 23.14 Mn |
| Sep 30, 2025 | 26.50 Mn |
| Jun 30, 2025 | 27.53 Mn |
| Mar 31, 2025 | 25.27 Mn |
| Dec 31, 2024 | 25.35 Mn |
| Sep 30, 2024 | 42.62 Mn |
| Jun 30, 2024 | 34.75 Mn |
| Mar 31, 2024 | 16.30 Mn |
| Dec 31, 2023 | 15.29 Mn |
| Sep 30, 2023 | 13.35 Mn |
| Jun 30, 2023 | 12.22 Mn |
| Mar 31, 2023 | 12.68 Mn |
| Dec 31, 2022 | 15.37 Mn |
| Sep 30, 2022 | 10.50 Mn |
| Jun 30, 2022 | 9.93 Mn |
| Mar 31, 2022 | 14.15 Mn |
| Dec 31, 2021 | 12.73 Mn |